Is there an alternative to finasteride for enlarged prostate?

Several well-studied alternatives to finasteride exist for treating an enlarged prostate, ranging from other prescription medications to office-based procedures and, in more advanced cases, surgery. Finasteride works by blocking the enzyme that converts testosterone into dihydrotestosterone (DHT), which drives prostate growth, and it does this effectively. But its sexual side effects and slow onset lead many men to look elsewhere. The good news is that the alternatives are not just “second best” options; depending on the severity of your symptoms and what matters most to you, some of them may actually be a better fit than finasteride ever was.

Why Men Look for Alternatives

Finasteride lowers DHT levels inside the prostate dramatically. One study found it cut intraprostatic DHT by over 90%, and this hormonal shift is exactly what shrinks the gland over time.¹ The problem is that DHT does not only affect the prostate. Suppressing it can cause decreased libido, erectile dysfunction, and reduced ejaculate volume. Reports also describe a cluster of persistent sexual, neuropsychiatric, and physical symptoms in some men even after stopping the drug, sometimes called post-finasteride syndrome.² While most men tolerate finasteride without serious issues, those who experience side effects or who have a history of depression or sexual dysfunction have strong reasons to explore other paths. Men with mild symptoms sometimes prefer to avoid daily medication altogether.

Alpha-Blockers: The Fastest-Acting Drug Alternative

Alpha-blockers like tamsulosin, alfuzosin, silodosin, and doxazosin are probably the most common first-line alternative. They work through a completely different mechanism than finasteride: instead of shrinking the prostate, they relax the smooth muscle in the prostate and bladder neck, making it physically easier for urine to pass through. This means symptom relief can begin within days rather than the months finasteride requires.

In head-to-head comparisons, alpha-blockers tend to outperform finasteride for short-term symptom relief. A direct trial comparing tamsulosin and finasteride found tamsulosin improved symptom scores more and did so faster, with statistically significant advantages in urinary flow rate as early as the first week of treatment.³ A broader review of trials confirmed the pattern: alpha-blockers are more effective than finasteride at reducing symptom scores in the short term.⁴

The trade-off is that alpha-blockers do nothing to stop the prostate from continuing to grow. Over years, a man on an alpha-blocker alone may find his symptoms creeping back as the gland gets larger. Alpha-blockers also come with their own side effects, particularly dizziness, lightheadedness from drops in blood pressure, and in some cases retrograde ejaculation (where semen goes into the bladder instead of out). For men whose prostates are not dramatically enlarged but whose symptoms are bothersome, an alpha-blocker alone is often enough.

Dutasteride: A Close Cousin, Not a True Departure

If finasteride’s mechanism appeals to you but its specific formulation does not, dutasteride is the main within-class alternative. Both drugs block the enzyme 5-alpha-reductase to lower DHT, but finasteride targets only the type 2 form of that enzyme, while dutasteride blocks both type 1 and type 2. This dual inhibition means dutasteride lowers serum DHT more than finasteride does.⁵ In practice, though, the clinical outcomes are strikingly similar: prostate volume reduction, urinary flow rate improvement, symptom scores, and long-term risk reduction for acute urinary retention and surgery all come out roughly equivalent between the two drugs.⁶

Because the mechanism is shared, the sexual side effect profile is also similar. Dutasteride is not typically the answer for a man trying to escape finasteride’s side effects. It is, however, sometimes useful for men whose prostate tissue has higher expression of the type 1 enzyme, or for those whose doctor prefers its longer half-life for more stable drug levels.

Tadalafil: One Pill for Two Problems

Tadalafil (the active ingredient in Cialis) was originally approved for erectile dysfunction, but a low daily dose of 5 mg is now also approved for lower urinary tract symptoms caused by an enlarged prostate. This makes it uniquely appealing for men who have both conditions, which is common since they tend to appear in the same age group.

A meta-analysis found that tadalafil 5 mg once daily significantly improved symptom scores and quality-of-life measures compared to placebo over 12 weeks.⁷ It works by relaxing smooth muscle in the prostate, bladder, and blood vessels. Importantly, rather than causing sexual side effects, it treats them. A review noted that tadalafil avoids the sexual adverse events associated with alpha-blockers and 5-alpha-reductase inhibitors and is currently the only drug that can address both erectile dysfunction and urinary symptoms simultaneously.⁸

Tadalafil does not shrink the prostate. Like alpha-blockers, it manages symptoms rather than altering the disease’s trajectory. Its typical side effects include headache, back pain, and nasal congestion. Men on nitrate medications for heart disease cannot take it due to dangerous blood pressure drops.

Combination Therapy: Using Two Drugs Together

For men with significantly enlarged prostates and moderate-to-severe symptoms, combining an alpha-blocker with a 5-alpha-reductase inhibitor is a well-studied strategy. The landmark MTOPS trial found that combination therapy with doxazosin and finasteride reduced the risk of overall disease progression by about two-thirds compared to placebo, significantly more than either drug alone.⁹ The alpha-blocker handles immediate symptom relief while the 5-ARI works over months to shrink the gland and reduce the risk of acute urinary retention or the need for surgery.

A four-year study of dutasteride combined with tamsulosin (the CombAT trial) confirmed that combination therapy was superior to either drug alone for symptom improvement and reducing the risk of disease progression.¹⁰ This approach still involves a 5-ARI, so it is not a finasteride-free path, but some men find that the alpha-blocker’s quick symptom relief and the lower dutasteride dose used in some combination regimens make the overall package more tolerable. If avoiding all 5-ARIs is the goal, combination therapy is not the answer.

Saw Palmetto and Other Plant-Based Options

Saw palmetto extract, from the berries of the Serenoa repens palm, is the most widely used herbal remedy for prostate symptoms worldwide. An early systematic review in JAMA found that men taking saw palmetto experienced reduced nocturia (nighttime urination), improved self-rated symptoms, and better urinary flow compared to placebo. When compared directly to finasteride, improvements in symptom scores and flow rates were similar, while erectile dysfunction occurred significantly less often with saw palmetto than with finasteride.¹¹

The catch is that later, larger, and more rigorous trials painted a less encouraging picture. Several well-designed studies found saw palmetto performed no better than placebo on standard symptom scores, and the enthusiasm in the urology community has cooled considerably since those early reviews. If you try saw palmetto, the evidence suggests it is quite safe and unlikely to cause harm, but you should not expect the same magnitude of benefit that prescription drugs provide, and you should let your doctor know you are taking it.

Beta-sitosterol, a plant sterol found in various foods and supplements, has also shown modest promise. A Cochrane review found it improved symptom scores and urinary flow measures compared to placebo.¹² However, the improvements are generally smaller than what prescription alpha-blockers or 5-ARI drugs achieve, and long-term data is limited. Some researchers have suggested beta-sitosterol may be most appropriate for younger men with mild symptoms who are not ready to start pharmaceutical treatment.¹³

Minimally Invasive Procedures

For men who want to move beyond pills entirely, several office-based or outpatient procedures can physically open the blocked urinary channel without the recovery time or risks of traditional surgery. Two have accumulated enough evidence to become mainstream options.

The UroLift system (also called prostatic urethral lift, or PUL) uses small implants to pin back the lobes of the prostate that are squeezing the urethra, essentially stapling the tissue out of the way. It typically takes under an hour and can be done under local anesthesia. Rezūm (water vapor thermal therapy) uses steam injections to destroy excess prostate tissue, which the body then reabsorbs over several weeks. Both have been highlighted as leading minimally invasive options backed by strong clinical data.¹⁴

Across studies, these procedures reduced symptom scores by roughly 8 to 17 points on the standard scale and improved peak urinary flow by 3 to 12 mL per second. UroLift stands out for preserving ejaculatory function due to its non-ablative design, while Rezūm provides durable relief with low rates of new erectile dysfunction, though some men experience temporary ejaculatory changes.¹⁵ For many men, these procedures hit a sweet spot between medication and surgery.

Cost is worth mentioning. A cost-effectiveness analysis found that water vapor thermal therapy (Rezūm) produced slightly more quality-adjusted life-years at lower lifetime cost than pharmacotherapy followed by either Rezūm or UroLift, and also lower cost than initial UroLift treatment. UroLift had notably higher retreatment rates at four years compared to Rezūm.¹⁶ A separate study comparing initial minimally invasive treatment against starting with drugs found that going straight to Rezūm led to the highest quality-adjusted life-years and the lowest overall cost, outperforming the traditional step-wise approach of trying medication first.¹⁷

Prostate Artery Embolization

Prostate artery embolization (PAE) is a newer, nonsurgical approach performed by an interventional radiologist. Tiny particles are injected into the arteries that feed the prostate, cutting off part of its blood supply and causing it to shrink. It is done through a small puncture in the wrist or groin, and most men go home the same day.

A study following men for a median of six years after PAE found an average improvement of 16 points on the standard symptom score, a nearly 40% reduction in prostate volume, and no cases of urinary incontinence or erectile dysfunction.¹⁸ When compared to traditional surgical resection (TURP), PAE outcomes are comparable, though TURP tends to edge ahead on some clinical measures. About one in four men in the long-term study experienced symptom recurrence, and the procedure was more likely to hold up when both sides of the prostate were treated.¹⁹ PAE is a particularly good fit for men who are not candidates for surgery, who want to preserve sexual function, or who simply prefer a nonsurgical route with a faster return to normal activity.

Surgery for Advanced Cases

When medications and minimally invasive options have not worked, or when the prostate is very large, surgery remains the most definitive solution. TURP (transurethral resection of the prostate) has been the reference standard for decades. It uses an instrument passed through the urethra to shave away obstructing tissue, and it delivers reliable, lasting symptom relief for most men.

Holmium laser enucleation of the prostate (HoLEP) has increasingly been recognized as a superior alternative, particularly for larger glands. It uses a laser to remove whole lobes of prostate tissue from the inside. A randomized trial comparing HoLEP to TURP found equivalent symptom scores, quality-of-life scores, and urinary flow rates at two years, but two patients in the TURP group needed reoperation while none in the HoLEP group did.²⁰ Over longer follow-up, HoLEP patients showed greater improvement in flow rates, better subjective symptom scores, and lower rates of repeat procedures compared to TURP and other laser therapies.²¹ The main downsides are that HoLEP requires specialized equipment and surgeon expertise that not all centers have, and retrograde ejaculation occurs in a majority of patients.

What Happens When You Stop Finasteride

If you are already on finasteride and considering switching to an alternative, one practical question is what happens to your prostate when you stop. The short answer: it grows back. Research shows the prostate returns toward its pre-medication size relatively quickly after discontinuation. One study found prostate volume increased by about 13% within a year of stopping dutasteride, although no patients in that study developed acute urinary retention or needed surgery in that timeframe.²² Other research found the prostate can return to about 95% of its original size within a year of stopping, along with worsening symptoms and rising PSA levels.²³

This means switching from finasteride to a non-shrinking alternative like an alpha-blocker is not seamless. You may need closer monitoring and should discuss the timing and transition plan with your urologist, especially if your prostate was substantially enlarged before treatment.

Lifestyle Changes and Metabolic Health

Lifestyle modification is not going to replace medication for a man with a severely enlarged prostate, but growing evidence suggests it plays a real supporting role. A review of studies on physical activity found that men engaging in moderate or heavy exercise had roughly a 25% lower chance of developing prostate symptoms or enlargement compared to sedentary men.²⁴ Dietary patterns matter too: a Mediterranean-style diet rich in antioxidants, fiber, and polyphenols and low in red meat may help reduce symptom severity by dialing down the metabolic inflammation that fuels prostate growth.²⁵

The metabolic connection is worth understanding. There is strong epidemiological evidence linking insulin resistance, obesity, and metabolic syndrome to more aggressive prostate growth and worse urinary symptoms.²⁶ High circulating insulin can directly promote prostate tissue growth through several molecular pathways.²⁷ Research into the molecular overlap between metabolic syndrome and prostate enlargement has suggested that treating metabolic dysfunction with appropriate medications could alleviate both conditions simultaneously.²⁸ In other words, getting blood sugar and weight under control is not just good general health advice; for men with prostate symptoms, it may be directly addressing one of the forces driving their condition.

How to Think About Choosing

The right alternative depends heavily on where you are in the disease. For mild symptoms and a modestly enlarged prostate, lifestyle changes, an alpha-blocker, or even careful watchful waiting may be all you need. For moderate symptoms, especially with coexisting erectile dysfunction, daily low-dose tadalafil is worth a serious conversation with your doctor. For men with very large prostates who need something to halt growth, dutasteride is the only real drug-class alternative, and it carries the same fundamental trade-offs. For men with moderate-to-severe symptoms who want to avoid long-term medication entirely, Rezūm or UroLift can provide durable relief with minimal sexual side effects and are increasingly shown to be cost-effective even as a first treatment. And for the largest prostates or those that have not responded to anything else, HoLEP or TURP remain the most reliable long-term fixes.

Fluid restriction in the evening, reducing caffeine and alcohol, and timed voiding are simple behavioral strategies that complement any treatment. They will not replace a procedure or medication, but many men are surprised by how much symptom relief they gain from tactics that cost nothing and carry zero side effects. Whatever route you choose, the key point is that finasteride is far from the only option, and for many men, it is not even the best one.